Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

MESALAMINE

FDA · NDA · 2026-10-14

AgencyFDA
Submission typeNDA
Action date2026-10-14
BrandROWASA
SponsorMYLAN SPECIALITY LP
RouteRECTAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:30.577Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:MESALAMINE:2026-10-14

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

MESALAMINE — approval | AEaH